These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8432774)

  • 1. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
    Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
    J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids.
    Lim CF; Docter R; Visser TJ; Krenning EP; Bernard B; van Toor H; de Jong M; Hennemann G
    J Clin Endocrinol Metab; 1993 May; 76(5):1165-72. PubMed ID: 8496307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a furan fatty acid and indoxyl sulfate on thyroid hormone uptake in cultured anterior pituitary cells.
    Everts ME; Lim CF; Moerings EP; Docter R; Visser TJ; De Jong M; Krenning EP; Hennemann G
    Am J Physiol; 1995 May; 268(5 Pt 1):E974-9. PubMed ID: 7762653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of uremic toxins on hepatic uptake and metabolism of erythromycin.
    Sun H; Huang Y; Frassetto L; Benet LZ
    Drug Metab Dispos; 2004 Nov; 32(11):1239-46. PubMed ID: 15286055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of uremic serum and uremic toxins on hepatic uptake of digoxin.
    Tsujimoto M; Kinoshita Y; Hirata S; Otagiri M; Ohtani H; Sawada Y
    Ther Drug Monit; 2008 Oct; 30(5):576-82. PubMed ID: 18708994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of thyroxine into cultured hepatocytes: effects of mild non-thyroidal illness and calorie restriction in obese subjects.
    Lim CF; Docter R; Krenning EP; van Toor H; Bernard B; de Jong M; Hennemann G
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):79-85. PubMed ID: 8306485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
    Deguchi T; Ohtsuki S; Otagiri M; Takanaga H; Asaba H; Mori S; Terasaki T
    Kidney Int; 2002 May; 61(5):1760-8. PubMed ID: 11967025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid.
    Tsutsumi Y; Maruyama T; Takadate A; Shimada H; Otagiri M
    Nephron; 2000 May; 85(1):60-4. PubMed ID: 10773757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats.
    Deguchi T; Kouno Y; Terasaki T; Takadate A; Otagiri M
    Pharm Res; 2005 Apr; 22(4):619-27. PubMed ID: 15846470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uricosuric agents in uremic sera. Identification of indoxyl sulfata and hippuric acid.
    Boumendil-Podevin EF; Podevin RA; Richet G
    J Clin Invest; 1975 Jun; 55(6):1142-52. PubMed ID: 1133164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-bound uremic retention solutes.
    Brunet P; Dou L; Cerini C; Berland Y
    Adv Ren Replace Ther; 2003 Oct; 10(4):310-20. PubMed ID: 14681860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.
    Tsutsumi Y; Deguchi T; Takano M; Takadate A; Lindup WE; Otagiri M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):880-7. PubMed ID: 12388676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
    Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of protein-bound uraemic toxins by haemodialysis.
    Niwa T
    Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of protein-bound uraemic toxins on the thermodynamic characteristics of human albumin.
    Sarnatskaya VV; Lindup WE; Niwa T; Ivanov AI; Yushko LA; Tjia J; Maslenny VN; Korneeva LN; Nikolaev VG
    Biochem Pharmacol; 2002 Apr; 63(7):1287-96. PubMed ID: 11960605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
    Lesaffer G; De Smet R; Lameire N; Dhondt A; Duym P; Vanholder R
    Nephrol Dial Transplant; 2000 Jan; 15(1):50-7. PubMed ID: 10607767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin.
    Dasgupta A; Havlik D
    Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Plasma Exposures of Conjugated Metabolites of Morinidazole in Renal Failure Patients: A Critical Role of Uremic Toxins.
    Kong F; Pang X; Zhong K; Guo Z; Li X; Zhong D; Chen X
    Drug Metab Dispos; 2017 Jun; 45(6):593-603. PubMed ID: 28314825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?
    Eloot S; Van Biesen W; Glorieux G; Neirynck N; Dhondt A; Vanholder R
    PLoS One; 2013; 8(11):e76838. PubMed ID: 24236005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.